Shield Therapeutics set to put listing plans on hold

Shield Therapeutics, which last month announced plans for a London listing, is expected to say it will put its plans on hold until market conditions stabilise.

Sources close to the drug developer told the Sunday Times that the company has held emergency discussions this weekend, with it looking likely the plans to delay the listing will be announced this week.

BHP Billiton, which is set to sell a multi-billion-pound hybrid bond, is also expected to postpone its fundraising plans amid concerns about a slowdown in growth in China, weak jobs data from the US and fears over commodity prices.